Assistant Professor

Tel: (901) 523-8990


  • Other, VCU, Richmond, VA, Interventional Cardiology
  • Other, University of Louisville , KY, Cardiology
  • Other, Brigham &Women /Harvard, Boston MA, Research/Imaging fellowship
  • Other, Yale University New Haven CT, Research/Nuclear fellowship
  • Other, Duke University Durham NC, Internal Medicine Residency
  • M.D., Aga Khan University Pakistan, Medicine


  1. Shah R. Bioresorbable Vascular Scaffolds and Stent Thrombosis. Annals of Internal Medicine 2016 (In-press).
  2. Shah R. Linagliptin for elderly patients with type 2 diabetes.. Lancet. 2014 Jan 25;383(9914):306-7.
  3. Shah R, McMurray JM, Kober L, Pfeffer MA. Cardiac Structure and Function in Diabetics with Acute Myocardial infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both: the VALIANT Echo Study. JACC. 2007. 49(9); S1: A42-A98..
  4. Chung LH, Shah R, Hou LJ, Yeh HI. Role Of Regional Geometric Dyssynchrony By Real-time Three-dimensional Echocardiography As A Determinant Of Functional Mitral Regurgitation In Patients With Acute Myocardial Infarction. Circulation. 2007;116:II-764..
  5. Shah, R. Shelton MR.. Lesson of the month 1: broken heart in the intensive care unit. Clinical Medicine. 2014; 14 (4)..
  6. Shah R, Keough LA, Belalcazar-Portacio A, Ramanathan KB.. Ticagrelor as an alternative in clopidogrel-associated neutropenia.. Platelets. 2014 Jan 16;.
  7. Shah R, Khan MR, Matin K.. Preventive angioplasty in myocardial infarction.. New England J Med 2014;370(3):281.
  8. Shah R, Duncan S. Ramanathan KB.. Cocaine induced ST elevation MI.. Acute Med. 2014;13(2):72-3.
  9. Shah R, Matin K.. New oral anticoagulants in patients with atrial fibrillation.. Lancet. 2014;384:23-24.
  10. Shah R. Myocardial ischemic events in 'real world' patients treated with dabigatran.. Am J Med; 2014 Oct;127(10):e19.
  11. Shah R, Roberts KM, Ramanathan KB.. Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation. JAMA. 2014;311(24):2542..
  12. Shah R, Mooney MA.. Complete versus culprit-only revascularisation for ST-segment elevationmyocardial infarction. Heart 2016.
  13. Shah R, Burg MM, Vashist A, Collins D, Liu J, Jadbabaie F, Graeber B, Earley C, Lampert R, Soufer R.. C-reactive protein and vulnerability to mental stress-induced myocardial ischemia.. Molecular Medicine (2006)12;10..
  14. Shah R, Wang Y, Foody JM.. Gender and racial difference in the outcomes and guideline-based management of troponin only positive acute myocardial infarction in older persons. Am J Geriatr Cardiology (2006)15;5..
  15. Shah R, Wang Y, Foody JM.. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.. American Journal of Cardiology 2008 Jan 15;101(2):217-222..
  16. Shah R.. Pioglitazone vs glimepiride in the PERISCOPE trial. JAMA. 2008 Aug 20;300(7):787-8..
  17. Shah R.. Protease-activated receptors in cardiovascular health and diseases.. Am Heart J. 2009 Feb;157(2):253-62.
  18. Shah R, Rashid A, Deam AG.. Dangerous cold Beverages.. Am J Med; 2014. 127(7):e3-4.
  19. Shah, R.. Renal denervation for resistant hypertension-the Symplicity HTN-1 study.. Lancet.2014; 383(9932):1885.
  20. Shah R, Khan, MR.. Comparative safety of vascular closure devices.. Annals of internal Medicine. 2014:160(6):438..
  21. Shah R.. Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. J Am Coll Cardiol Intv. 2016;9(14):1517-1518.
  22. Foody JM, Shah R, Galusha D, Greenspan M, Masoudi FA, Havranek EP, Krumholz HM.. Statins and mortality among elderly patients hospitalized with heart failure.. Circulation. 2006; 113:1086 – 1092..
  23. Shah R, Wang Y, Masoudi FA, Havranek EP, Foody JM.. Prognosis of troponin only positive myocardial infarction in elderly. Crit Pathways in Cardiol 2006;5: 160-166.
  24. Shah,R. Endothelins in Health and Diseases. Eur J Intern Med. 2007 Jul;18(4):272-82.
  25. Shah R. Routine Ischemic Work-up for Patients with New Onset Heart Failure. JACC 2016 (In press)..
  26. Shah R, et al.. Meta-Analysis Comparing Complete Revascularization versus Infarct Related Only Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multi-vessel Coronary Artery Disease. American Journal of Cardiology 2016 (In press).
  27. Shah R.. Invasive Strategy for Acute Coronary Syndrome in The Very Elderly. Lancet 2016.
  28. Shah R, Foody J. Caring for the advanced elderly with acute coronary syndromes. Cardiology Reports. 2006; 8(4): 289-95.
  29. Shah, R. Optimum technique to reduce risk of stent thrombosis. Lancet, 388 (10040), 127, 2016.
  30. Shah, R, Rogers, KC, Ahmed, AJ, King, BJ, Rao, SV. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv, 9 (13), 1313-20, 2016.
  31. Shah, R, Rashid, A, Mizeracki, A. An Elderly Unresponsive Patient. JAMA, 315 (17), 1896-7, 2016.
  32. Shah, R, Ramos-Bondy, B, Mizeracki, A. Risk of stent thrombosis with bioresorbable vascular scaffolds. Lancet, 387 (10031), 1903, 2016.
  33. Shah, R, Khan, MR, Holt, LC. An Elderly Patient With Palpitation and a Negative Nuclear Stress Test Result. JAMA Intern Med, 176 (4), 542-4, 2016.
  34. Shah, R, John, E, Fan, TH, Ruff, G, Rehan Khan, M, Holt, LC. A Patient with Metastatic Small-Cell Lung Cancer and Giant Right Ventricular Mass. Echocardiography, 33 (3), 491-3, 2016.
  35. Shah, R, Qualls, Z. Diaphragmatic stimulation caused by cardiac resynchronization treatment. CMAJ, 2016.
  36. Shah, R, Rogers, KC, Matin, K, Askari, R, Rao, SV. An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention. Am Heart J, 171 (1), 14-24, 2016.
  37. Rao SV, Shah R. The Fuzzy Math of Anticoagulation and Access Site: When 1 + 1 Does Not Always Equal 2 (Editorial).. JACC Cardiovascular interventions., 2016.
  38. Shah R. Invasive strategy in acute coronary syndrome. Lancet, 387 (387), 2503, 2016.
  39. Shah, R. Bivalirudin in Acute Coronary Syndromes. N Engl J Med, 374 (3), 285, 2016.
  40. Shah, R, Gardner, JD. Radial versus femoral access for cardiac catheterisation. Lancet, 386 (10011), 2392-3, 2015.
  41. Shah, R, Berzingi, C, Fan, TH, Askari, R, Khan, MR. Cocaine-Induced Acute Aortic Dissection. J Emerg Med, 49 (3), e87-9, 2015.
  42. Shah, R. Bivalirudin versus heparin use for patients undergoing PPCI. Lancet, 385 (9982), 2045, 2015.
  43. Shah, R. β blockers in patients with heart failure and atrial fibrillation. Lancet, 385 (9978), 1618, 2015.
  44. Shah, R, Khan, MR, Fan, TH, Ruff, G, Ramanathan, KB. An 81-year-old man with an abnormal right-sided heart shadow on chest radiograph. Chest, 147 (2), e52-5, 2015.
  45. Shah, R. Fractional flow reserve-guided PCI. N Engl J Med, 372 (1), 94-5, 2015.
  46. Shah, R, Deam, AG. Wide complex tachycardia in a patient with a family history of sudden death. JAMA Intern Med, 175 (1), 128-31, 2015.
  47. Shah, R, Slomka, T, Rogers, KC. Dual antiplatelet treatment after stenting. Lancet, 385 (9965), 326, 2015.